Dabur India Ltd 2018-19 Financial Results

New Delhi, May 2, 2019: The Board of Directors of Dabur India Ltd (DIL) met here today to consider the audited financial results of the company for the quarter and year ended March 31st, 2019.

 

Steady growth in the domestic market helped Dabur India Ltd close the 2018-19 financial year with a 10.1% Revenue Growth. Dabur ended 2018-19 with an 11% Volume Growth in the India FMCG business with strong gains in Market Shares across key categories.

 

 

“The gradual recovery of the domestic market was temporarily impacted by adverse liquidity conditions and the agrarian crisis, particularly towards the end of the financial year. Our India business demonstrated resilience and continued to report a steady growth with strong Market Share gains in key highly competitive categories. Dabur’s domestic FMCG business recorded a growth of 13% in 2018-19. The performance of our International Business was, however, relatively muted due to a challenging macro-economic environment. Going forward, we will continue to invest behind our brands to successfully tap the significant growth opportunities and deliver profitable volume-led growth,” Dabur India Ltd Chief Executive Officer Mr. Mohit Malhotra said.

 

The demand slowdown towards the end of the fiscal year due to the liquidity issues and a prolonged winter season in North India led to Dabur India Ltd ending the fourth quarter of 2018-19 with a Consolidated Revenue growth of 4.7% at Rs 2,128 Crore, up from Rs 2,033 Crore a year earlier. Dabur ended Q4 2018-19 with a Consolidated Net Profit of Rs 370 Crore. Net Profit for the fourth quarter was impacted by one-off exceptional charges. Dabur India Ltd Standalone Net Profit for Q4 of 2018-19 marked a 17.2% growth to Rs 414.3 Crore.

 

 

Riding on strong growth across its Hair Oils and Shampoos portfolio, Dabur’s Hair Care business ended 2018-19 with a 13.7% growth. The Health Supplements business ended the fiscal with a 13.6% growth while the Digestives category grew by 14.8%. The Ayurvedic OTC and Ethicals business ended with a 13% growth while Toothpaste business grew 9.6% in 2018-19. Dabur’s Skin Care business grew 16.2% in 2018-19 financial year. The Home Care business was up 11.5% in 2018-19.

 

 

Dabur’s Health Care portfolio reported a 11.2% growth in Q4 of 2018-19. The Health Supplements business was up 10.2% in Q4, led by strong double-digit growth in Dabur Chyawanprash. The OTC and Ayurvedic Ethicals business grew by 12.8% during the quarter, while the Toothpaste business, riding on continued demand for Dabur Red Paste, ended the quarter with a 9.3% growth. The Skin Care category reported an 11.2% growth during Q4 of 2018-19. The Home Care business, riding on strong demand for Odonil Air Freshener portfolio, ended Q4 with a 16.2% growth.

 

 

The Board of Directors today recommended a Final Dividend of 150%. “Continuing with our Dividend Payout policy, the Board has proposed a dividend of Rs 1.50 per share, aggregating to Rs. 319.41 Crore, including Dividend Tax,” Dabur India Ltd Chairman Dr. Anand C Burman said.

 

 

Dabur India Limited is one of India’s leading FMCG Companies. Building on a legacy of quality and experience for 135 years, Dabur is today India’s most trusted name and one of the world’s largest Ayurvedic and Natural Health Care Company. Dabur India's FMCG portfolio today includes five flagship brands with distinct brand identities – Dabur as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Réal for fruit-based beverages, and Fem for fairness bleaches & skin care.

 

 

Byas Anand

Corporate Communications

Dabur India Ltd

Ph.: +91-9811994902